APA

Kaya A. O., Coskun U., Ozkan M., Sevinc A., Yilmaz A. U., Gumus M., Unal O. U., Ozdemir N. Y., Alici S., Berk V., Degerli H., Oner M. K., Ozturk C., Kefeli U. & Camcı C. (20130322). Paclitaxel plus doxorubicin chemotherapy as second-line therapy in patients with advanced urothelial carcinoma pretreated with platinum plus gemcitabine chemotherapy. : Onkologie.

Chicago

Kaya Ali O, Coskun Ugur, Ozkan Metin, Sevinc Alper, Yilmaz Ahmet U, Gumus Mahmut, Unal Olcun U, Ozdemir Nuriye Y, Alici Suleyman, Berk Veli, Degerli Hatice, Oner Mehmet K, Ozturk Cemil, Kefeli Umut and Camcı Celalettin. 20130322. Paclitaxel plus doxorubicin chemotherapy as second-line therapy in patients with advanced urothelial carcinoma pretreated with platinum plus gemcitabine chemotherapy. : Onkologie.

Harvard

Kaya A. O., Coskun U., Ozkan M., Sevinc A., Yilmaz A. U., Gumus M., Unal O. U., Ozdemir N. Y., Alici S., Berk V., Degerli H., Oner M. K., Ozturk C., Kefeli U. and Camcı C. (20130322). Paclitaxel plus doxorubicin chemotherapy as second-line therapy in patients with advanced urothelial carcinoma pretreated with platinum plus gemcitabine chemotherapy. : Onkologie.

MLA

Kaya Ali O, Coskun Ugur, Ozkan Metin, Sevinc Alper, Yilmaz Ahmet U, Gumus Mahmut, Unal Olcun U, Ozdemir Nuriye Y, Alici Suleyman, Berk Veli, Degerli Hatice, Oner Mehmet K, Ozturk Cemil, Kefeli Umut and Camcı Celalettin. Paclitaxel plus doxorubicin chemotherapy as second-line therapy in patients with advanced urothelial carcinoma pretreated with platinum plus gemcitabine chemotherapy. : Onkologie. 20130322.